Application of High Throughput Technologies in the Development of Acute Myeloid Leukemia Therapy: Challenges and Progress

Acute myeloid leukemia (AML) is a complex hematological malignancy characterized by extensive heterogeneity in genetics, response to therapy and long-term outcomes, making it a prototype example of development for personalized medicine. Given the accessibility to hematologic malignancy patient sampl...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Wei, Lam, Yi Hui, Periyasamy, Giridharan, Chuah, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910862/
https://www.ncbi.nlm.nih.gov/pubmed/35270002
http://dx.doi.org/10.3390/ijms23052863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910862/
https://www.ncbi.nlm.nih.gov/pubmed/35270002
http://dx.doi.org/10.3390/ijms23052863

Ejemplares similares